Patent ID: 11945824
Assignee: ENANTA PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The compound of claim 1, represented by one of Formula (IXa) or (IXb), or a pharmaceutically acceptable salt thereof:, , wherein each R11 is independently optionally substituted —C1-C6 alkyl, optionally substituted —C1-C6 alkoxyl, optionally substituted —C3-C6 cycloalkyl, halo, —CN, or —NRaRb; Ra and Rb are independently selected from hydrogen, optionally substituted —C1-C6 alkyl, optionally substituted —C3-C6 cycloalkyl, alternatively, Ra and Rb are taken together with nitrogen atom to which they attached to form a heterocyclic ring; m is 0, 1, 2, 3, 4 or 5, A, Y, G, R3, and R4 are as defined in claim 1.